TABLE 4.
Collecting time | RV-A
|
No. (%) of samples positive for RV-B by RT-PCR | RV-C
|
|||||
---|---|---|---|---|---|---|---|---|
No. (%) of samples positive
|
No. of samples positive by CCIF/ no. tested by CCIF (%)c | |||||||
Seminested PCRb | ELISA | Seminested PCRb and ELISAd | Total | No. (%) of samples positive by seminested PCR | No. of samples positive by CCIF/ no. tested by CCIF (%)c | |||
Pretreatment (61) | 39 (64) | 0 (0) | 2 (3) | 41 (67) | 21/25 (84) | 0 (0) | 27 (44) | 14/17 (82) |
During treatment (75) | 29 (39) | 0 (0) | 3 (4) | 32 (43) | NA | 0 (0) | 41 (55) | NA |
Posttreatment (28) | 14 (50) | 0 (0) | 0 (0) | 14 (50) | 4/14 (29) | 0 (0) | 12 (43) | 2/12 (17) |
Total (164) | 82 (50) | 0 (0) | 5 (3) | 87 (53) | 25/39 (64) | 0 (0) | 80 (49) | 16/29 (55) |
NA, not applicable.
Seminested PCR was performed with primers GA75M/End-9.
A set of pretreatment samples and all posttreatment samples with a seminested PCR-positive result were tested by CCIF as indicated in the text.
Samples were positive by both ELISA and seminested PCR.